Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy

被引:0
作者
Feng Huang [1 ]
Jian Gao [2 ]
机构
[1] Second Clinical College, Chongqing Medical University
[2] Department of Gastroenterology, Second Affiliated Hospital, Chongqing Medical University
基金
中国国家自然科学基金;
关键词
Modified Child-Pugh grade; Albumin-Bilirubin grade; Hepatocellular carcinoma; Prognosis; Hepatectomy; Child-Pugh;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Hepatectomy is the main treatment for patients with hepatocellular carcinoma(HCC) and it has a high possibility for long-term cure potential. But the postoperative mortality and recurrence rates remain high. Since the long-term prognosis of HCC patients is strongly linked to liver function, preoperative assessment of liver function is very important for HCC patients.AIM To compare the predictive power of the modified Child-Pugh(MCP) and albumin-bilirubin(ALBI) grades for the long-term outcome of HCC.METHODS From January 2010 to June 2017, a total of 204 patients with HCC who underwent surgery at the Second Affiliated Hospital of Chongqing Medical University were enrolled in this retrospective study. Multivariate Cox regression analysis was used to determine the independent predictive factors of survival and relapse. The area under the curve(AUC) was used to evaluate the discriminative performance of the MCP grade and ALBI grade to predict the postoperative overall survival(OS) time and recurrence-free survival(RFS) time.RESULTS The median OS and RFS times were 44.0 mo(range: 22.0-74.0 mo) and 22.0 mo(range: 5.0-45.0 mo), respectively. The median OS and RFS times of MCP grades1, 2, and 3 patients were 60.0, 39.0, and 18.0 mo(P < 0.001) and 36.0, 15.0, and 7.0 mo(P < 0.001), respectively. The median OS and RFS times of ALBI grades 1, 2,and 3 patients were 56.0, 26.0, and 6.0 mo(P < 0.001) and 25.0, 10.0, and 3.0 mo(P= 0.003), respectively. Both the MCP and ALBI grades were more accurate than the Child-Pugh grade for predicting long-term prognosis. Further analysis demonstrated that for both predicting OS and RFS, the MCP grade performed better than the ALBI grade(AUC: 0.642 vs 0.605 for OS; 0.659 vs 0.594 for RFS).CONCLUSION The MCP grade is more accurate than the ALBI grade for predicting long-term outcome of patients with HCC.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 50 条
  • [21] Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Xu, Lin
    Wu, Jing
    Lu, Wenzhu
    Yang, Chunmei
    Liu, Hong
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (10) : 3338 - 3346
  • [22] Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm
    kudo, Masatoshi
    [J]. LIVER CANCER, 2017, 6 (03) : 185 - 188
  • [23] Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade
    Kumada, Takashi
    Toyoda, Hidenori
    Tada, Toshifumi
    Yasuda, Satoshi
    Tanaka, Junko
    [J]. LIVER CANCER, 2020, 9 (05) : 518 - 528
  • [24] Post-operative albumin-bilirubin grade predicts long-term outcomes among Child–Pugh grade A patients with hepatocellular carcinoma after curative resection
    Masataka Amisaki
    Ei Uchinaka
    Masaki Morimoto
    Naruo Tokuyasu
    Teruhisa Sakamoto
    Soichiro Honjo
    Hiroaki Saito
    Yoshiyuki Fujiwara
    [J]. Hepatobiliary & Pancreatic Diseases International, 2018, 17 (06) : 502 - 509
  • [25] A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade
    Zhong, Cheng-Rui
    Qiu, Ji-Liang
    Yuan, Yi-Chuan
    Qiu, Zhi-Yu
    Li, Kai
    Wang, Chen-Wei
    Shi, Yun-Xing
    Li, Ke-Ren
    Lin, Zhu
    Huang, Zhen-Kun
    He, Wei
    Li, Bin-Kui
    Yuan, Yun-Fei
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (06): : 2711 - 2720
  • [26] Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade
    Honmyo, Naruhiko
    Kobayashi, Tsuyoshi
    Hamaoka, Michinori
    Kohashi, Toshihiko
    Abe, Tomoyuki
    Oishi, Koichi
    Tazawa, Hirofumi
    Imaoka, Yasuhiro
    Akita, Tomoyuki
    Tanaka, Junko
    Ohdan, Hideki
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (10) : 1218 - 1226
  • [27] Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment
    Hu, Keshu
    Yuan, Jia
    Tang, Bei
    Zhang, Feng
    Lu, Shenxin
    Chen, Rongxin
    Zhang, Lan
    Ren, Zhenggang
    Yin, Xin
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [28] Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade
    Ho, Shu-Yein
    Yuan, Mei-Hsia
    Liu, Po-Hong
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Liao, Jia-, I
    Su, Chien-Wei
    Wang, Chia-Lin
    Hou, Ming-Chih
    Huo, Teh-la
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (01) : 61 - 69
  • [29] Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases
    Feng, Dayun
    Wang, Mengmeng
    Hu, Jie
    Li, Songlun
    Zhao, Shoujie
    Li, Huichen
    Liu, Lei
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (08)
  • [30] Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort
    Li, Mu-xing
    Zhao, Hong
    Bi, Xin-yu
    Li, Zhi-yu
    Huang, Zhen
    Han, Yue
    Zhou, Jian-guo
    Zhao, Jian-jun
    Zhang, Ye-fan
    Cai, Jian-qiang
    [J]. HEPATOLOGY RESEARCH, 2017, 47 (08) : 731 - 741